MedTrace Logo

Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome

NCT01268709 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2010-12-31

No results posted yet for this study

Summary

The objective of this randomized triple blind controlled trial is to compare the effects of Doxepin and Nortriptyline on diarrhea predominant irritable bowel syndrome. In this stuy, 75 patients with IBS are randomly assigned to receive Doxepin , Nortriptyline or placebo, a tablet per day, orally, for two months. Abdominal pain, mucus in the stool, incomplete evacuation, and bloating are measured and compared between groups at the baseline and one and two month after the intervention.

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

Doxepin

DRUG

Nortriptyline

DRUG

placebo

Sponsors & Collaborators

  • Young Researchers Club

    collaborator UNKNOWN

  • Qom University of Medical Sciences

    lead OTHER

Study Design

Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268709 on ClinicalTrials.gov